With the exception of army pharmacists, pharmacists responsible, in application of article L. 1221-10, for monitoring labile blood products intended for direct therapeutic use in blood establishments must be registered in sections G or H of the national order of pharmacists or in section E if they practise in an overseas department or in the territorial collectivity of Saint-Pierre-et-Miquelon.